Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

PhRMA Launches New Ad Campaign to Improve Biopharma’s Image

XTALKS VITALS NEWS

Advertising

The ads will be featured on multiple media streams – including TV, print and digital – in an effort to repair the industry’s tarnished reputation after highly-publicized enquiries into drug price hikes.

Share this!

January 26, 2017 | by Sarah Hand, M.Sc.

Pharmaceutical industry trade group, PhRMA, has unveiled a new multimillion-dollar ad campaign named GoBoldly. The ads will be featured on multiple media streams – including TV, print and digital – in an effort to repair the industry’s tarnished reputation after highly-publicized enquiries into drug price hikes.

“Thanks to the tireless work of biopharmaceutical researchers and scientists, we have entered a new era of medicine that is transforming the way we prevent and treat disease,” said Stephen J. Ubl, president and chief executive officer of PhRMA. “This campaign spotlights their perseverance and unwavering commitment to American patients for whom we all work. We will also be convening events with stakeholders all across the country to discuss ways we can work together to make our health care system more responsive to the needs of patients.”

The first GoBoldy ad – “Do Not Go Gentle” – features video of scientists at work compiled with images of cells and blood flowing through vessels. The ad also includes Dylan Thomas’ poem of the same name being read aloud over the images and video.



In response to an ad campaign Ubl is calling, “less hoodie, more lab coats,” ex-pharma CEO Martin Shkreli created a website aimed at airing some of the industry’s dirty laundry. Pharmaskeletons.com names 26 pharma companies and how they’ve negatively contributed to the current state of drug pricing in the US.

In a few weeks, the trade organization will release their next ad – “Cells” – which reportedly shows video of a cancer cell self-destructing. The new ad campaign sends a stronger message compared to PhRMA’s previous emotionally-driven “From Hope to Cures” campaign.

However, this new attempt by the industry to improve public relations makes no mention of changing the pricing practices which have become such a hot-button issue in the industry today. Instead the multiyear campaign will focus on the most exciting new advancements in science and medicine, value-driven healthcare and public health matters.


Keywords: Advertising, Biopharma, Pharmaceutical Industry


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
New Self-Injectable Form of Lupus Drug Approved by the FDA

July 25, 2017 - Patients with systemic lupus erythematosus (SLE) will now have the option to self-inject their medication thanks to the FDA approval of GSK’s reformulated lupus drug, Benlysta (belimumab).

Featured In: Biotech News


Canadian Chicken Farmers to Further Reduce Use of Antibiotics

July 24, 2017 - The Chicken Farmers of Canada, a national group dedicated to supporting poultry farmers and helping them meet consumer demand for chicken, has announced their strategy for eliminating the use of certain antimicrobials in meat production.

Featured In: Food News


Neonatal MRI Medical Device Approved by the FDA

July 24, 2017 - Medical device maker Aspect Imaging has received US Food and Drug Administration (FDA) approval for its Embrace Neonatal MRI System.

Featured In: Medical Device News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Top 5 Most Impactful Tweets from #AAIC17

REGISTER FOR THESE WEBINARS

Into the Great Wide Open: PTC’s Transformation & Global Journey to Bring Patients a First Ever Rare Disease Therapy


EDC and eSource: Combined for Better Data and Faster Insights


Using Model Reduction to Bridge the Quality Systems Pharmacology-Pharmacometrics Divide


How to Maximize Your Non-GLP Toxicology Studies: A Guide for Optimal Design and Methodology


Copyright © 2016-2017 Honeycomb Worldwide Inc.